UPC CFI 1470/2026

Apr 30, 2026·EP4512389 Unitary patent · DEGARELIX DRUG PRODUCT

Case details: Status
Written Phase
Action
Infringement
Category
Main infringement action
Parties: Claimants
FERRING B.V.Operating co.
FERRING INTERNATIONAL CENTER S.A.Operating co.
FERRING PORTUGUESA – PRODUTOS FARMACÊUTICOS, SOCIEDADE UNIPESSOAL, LDAOperating co.
FERRING S.A.S.Operating co.
FERRING PHARMACEUTICALS A/SOperating co.
Representatives
François Pochart-August Debouzy
Respondents
Accord Healthcare B.V.Operating co.
ACCORD HEALTHCARE FRANCE S.A.S.Operating co.
Accord Healthcare S.L.U.Operating co.
ACCORD HEALTHCARE POLSKA SP. Z O.O.Operating co.
LABORATORI FUNDACIÓ DAUOperating co.
PHARMADOX HEALTHCARE LIMITEDOperating co.
Accord Healthcare, Unipessoal Lda.Operating co.
Representatives
Jules Fabre-Taylor Wessing
Division: The Hague LD
Judges: Edger Brinkman
Robert van Peursem
Vincenzo Carni
Rudi Goedeweeck
Technology: Chemistry
Pharmaceuticals
Language: English
First decided: Jun 9, 2026
EPO Opposition: Accord Healthcare S.L.U.2026-06-01

How this compares

The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.

	Infringement found	Median days to first decision
All UPC	53% (62/117)	124
The Hague LD	Locked	Locked
Judge Edger Brinkman	Locked	Locked
Judge Robert van Peursem	—	Locked
Judge Vincenzo Carni	—	Locked
Judge Rudi Goedeweeck	Locked	Locked

At the UPC: FERRING B.V. (1 case)·Accord Group (8 cases)

Related cases

Decisions

Documents